← Back to the page you were readingYou opened this term from another page.

Inequitable conduct

Also called inequitable conduct defense, inequitable conduct before the USPTO

Published by Patsnap Team Updated 4 sources
Definition

Inequitable conduct is an equitable defense to patent infringement in US courts that can render the entire patent unenforceable, as the en banc Federal Circuit explained in Therasense v. Becton, Dickinson (2011)1.

Used byAccused infringers asserting an equitable defense in patent litigation1
AppliesMaterial misrepresentations or omissions made with specific intent to deceive the USPTO, under the Federal Circuit's 2011 Therasense test1
Not to confuse withThe duty of disclosure under 37 CFR 1.56, which governs disclosure to the USPTO1,2
Also see35 U.S.C. 257(c), on qualifying supplemental examination and its exceptions3
01

Specific intent to deceive

In Therasense (2011), the en banc Federal Circuit held that the accused infringer must prove specific intent to deceive the USPTO by clear and convincing evidence1. For nondisclosure of a reference, the en banc Federal Circuit in Therasense (2011) required proof that the applicant knew of the reference and its materiality and deliberately withheld it1.

The en banc Federal Circuit in Therasense (2011) allowed an inference of intent from circumstantial evidence only if specific intent to deceive is the single most reasonable inference from the evidence1. The en banc Federal Circuit in Therasense (2011) required courts to assess intent and materiality separately and barred inferring intent from materiality alone1.

02

But-for materiality and the exception

The en banc Federal Circuit in Therasense (2011) explained that the accused infringer must prove both intent and materiality by clear and convincing evidence and that materiality generally requires but-for proof1. For withheld prior art, the en banc Federal Circuit in Therasense (2011) directed courts to ask whether the USPTO would have allowed the claim had it known of the art, applying a preponderance-of-the-evidence standard for patentability and the broadest reasonable construction of the claims1.

The en banc Federal Circuit in Therasense (2011) treated affirmative acts of egregious misconduct, such as filing an unmistakably false affidavit, as material without but-for proof1. The en banc Federal Circuit in Therasense (2011) required but-for materiality for mere nondisclosure of prior art to the USPTO or omission of prior art references from an affidavit1. The Federal Circuit applied the exception in Intellect Wireless v. HTC (2013) to an unmistakably false declaration that the applicant failed to correct4.

03

What happens to the patent

The en banc Federal Circuit in Therasense (2011) explained that once the accused infringer meets the burden on intent and materiality, the court weighs the equities to decide whether the conduct warrants unenforceability of the entire patent1. The en banc Federal Circuit in Therasense (2011) explained that inequitable conduct as to any claim makes the entire patent unenforceable1.

Legal standardWhat it addresses
37 CFR 1.56The USPTO disclosure duty and the rule's definition of material information2
Therasense (en banc Federal Circuit, 2011)The separate intent and materiality requirements for the defense in court, including the general but-for rule and the exception for affirmative egregious misconduct1
04

Effect of supplemental examination

Under 35 U.S.C. 257(c)(1), subject to the exceptions below, a patent cannot be held unenforceable based on conduct relating to information that was unconsidered, inadequately considered or incorrect in an earlier examination of that patent if the information was considered, reconsidered or corrected during supplemental examination of the patent3. Making or omitting a request under section 257(a) is irrelevant to enforceability under section 2823.

  • Prior allegations: Under section 257(c)(2)(A), paragraph (1)'s protection does not apply to an allegation if, before the date of the section 257(a) request to consider, reconsider or correct the information underlying the allegation, it was pleaded with particularity in a civil action or set out with particularity in a notice the patent owner received under 21 U.S.C. 355(j)(2)(B)(iv)(II)3.
  • Patent enforcement actions: In an action under 19 U.S.C. 1337(a) or 35 U.S.C. 281, section 257(c)(2)(B) withholds paragraph (1)'s protection as to a defense raised in the action based on information considered, reconsidered or corrected pursuant to a section 257(a) request unless the supplemental examination and any reexamination ordered pursuant to the request are concluded before the action is brought3.
05

Questions people ask

Patsnap EurekaEureka IP

Check a product

FTO Search AI Agent

Turn product details into a reviewable search strategy, focused patent candidates, and evidence your IP team can take further.

Run FTO Search
Is a failure to disclose material information enough to establish inequitable conduct?

No, the en banc Federal Circuit in Therasense (2011) separately requires clear and convincing proof of specific intent to deceive the USPTO1.

Does a finding of inequitable conduct affect only the claim involved?

No, the en banc Federal Circuit in Therasense (2011) explained that inequitable conduct as to even one claim makes the entire patent unenforceable1.

Does USPTO materiality under Rule 56 establish materiality for the court defense?

No. Rule 56(b) defines materiality for the USPTO disclosure duty2. The en banc Federal Circuit in Therasense (2011) declined to adopt that definition for inequitable conduct and generally requires but-for materiality, with an exception for affirmative egregious misconduct1,2.

06

How it connects

Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toHow to run a freedom-to-operate analysisScope, search, claim review and the report counsel will ask for.GuideRead
  • 02 / AI agentFTO Search AI AgentTurn product details into a reviewable search strategy, focused patent candidates, and evidence your IP team can take further.Patsnap EurekaRun it
  • 03 / Free toolAI prior art searchDescribe an idea, get the closest patents.AI resultTry tool
PublishedPatsnap Team
Updated 18 November 2026
Sources
  1. Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011) (en banc). U.S. Court of Appeals for the Federal Circuit · en banc opinion · 2011. Accessed 18 November 2026.
  2. Duty to disclose information material to patentability. U.S. Patent and Trademark Office · regulation · 2012. Accessed 18 November 2026.
  3. 35 U.S.C. 257: Supplemental examinations to consider, reconsider, or correct information. Office of the Law Revision Counsel, U.S. House of Representatives · statute · 2011. Accessed 18 November 2026.
  4. Intellect Wireless, Inc. v. HTC Corp., 732 F.3d 1339. U.S. Court of Appeals for the Federal Circuit · opinion · 2013. Accessed 18 November 2026.
Disclaimer

General information only. This page explains a term and is provided for general information and reference only. It is not legal advice and must not be relied upon as such. It does not create an attorney-client relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 18 November 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

No characterisation of the parties or the outcome. Where this page cites a court record or decision, it reports what that record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed. The filing of a claim is not a court finding, and a docket marked “closed” does not by itself establish infringement, validity, settlement or a decision on the merits.

Third-party names and marks. Party, attorney, judge and company names appear for identification only. Company names may be trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap.

Corrections. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why.

FTO Search AI AgentRun FTO Search in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.